文献速递慢性肾脏病血液净化与透析肾移植

2002-2013年澳大利亚1型和2型糖尿病患者终末期肾病发病率趋势

Trends in Incidence of ESKD in People With Type 1 and Type 2 Diabetes in Australia, 2002-2013.
PubMed 文献 · Am J Kidney Dis · 2018-12-19

该研究基于澳大利亚国家糖尿病服务计划登记数据,随访1,375,877名糖尿病患者至2013年,共9,977例发生终末期肾病(ESKD),总发病率为10.0/10,000人年(95%CI 9.8-10.2)。1型糖尿病患者的年龄标化年发病率保持稳定;2型糖尿病非原住民患者发病率上升(年变化百分比2.2%,95%CI 0.4%-4.1%),原住民与非原住民调整后发病率比为4.03(95%CI 3.68-4.41)。

要点

  • 糖尿病患者ESKD总发病率为10.0/10,000人年(95%CI 9.8-10.2)。
  • 2型糖尿病非原住民患者ESKD发病率年增2.2%(95%CI 0.4%-4.1%)。
  • 原住民ESKD调整后发病率是非原住民的4.03倍(95%CI 3.68-4.41)。

核心结论

  • 2002-2013年澳大利亚非原住民2型糖尿病患者的年龄标化ESKD年发病率上升,而1型糖尿病患者保持稳定。
  • 需加强预防ESKD,尤其针对澳大利亚原住民和早发2型糖尿病患者。

研究设计与样本

  • 基于全国卫生服务登记系统的随访研究。
  • 纳入澳大利亚国家糖尿病服务计划中1型或2型糖尿病登记患者,共1,375,877人。

主要发现

  • 共9,977例发生ESKD,总发病率为10.0/10,000人年(95%CI 9.8-10.2)。
  • 1型糖尿病患者年龄标化年发病率在研究期间保持稳定。
  • 2型糖尿病非原住民患者发病率上升,年变化百分比2.2%(95%CI 0.4%-4.1%),50岁以下和80岁以上增幅最大。
  • 原住民患者发病率随时间无显著变化,但调整后发病率比原住民vs非原住民为4.03(95%CI 3.68-4.41)。

临床怎么用

  • 对2型糖尿病非原住民患者,尤其50岁以下和80岁以上者,应加强ESKD预防。
  • 原住民糖尿病患者ESKD风险显著增高,需重点关注。

局限性

  • 缺乏合并症、用药、医疗质量指标和基线肾功能等协变量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: The number of people with diabetes and end-stage kidney disease (ESKD) is increasing worldwide, but it is unknown whether this indicates an increasing risk for ESKD in people with diabetes. We examined temporal trends in the incidence of ESKD within the Australian population with diabetes from 2002 to 2013. STUDY DESIGN: Follow-up study using a national health care services registry. SETTING & PARTICIPANTS: Registrants with type 1 or type 2 diabetes in Australia's National Diabetes Services Scheme (NDSS). PREDICTORS: Age, sex, indigenous status, diabetes type, and calendar year. OUTCOME: Incidence of ESKD (dialysis or kidney transplantation) or death ascertained using the Australian and New Zealand Dialysis and Transplant Registry and the Australian national death index. ANALYTICAL APPROACH: NDSS registrants were followed up from 2002 or date of registration until onset of ESKD, death, or December 31, 2013. The incidence of ESKD in type 1 diabetes was calculated only in those younger than 55 years. RESULTS: Among 1,375,877 registrants between 2002 and 2013, a total of 9,977 experienced incident ESKD, representing an overall incidence of ESKD in people with diabetes of 10.0 (95% CI, 9.8-10.2) per 10,000 person-years. Among those with type 1 diabetes, the age-standardized annual incidence was stable during the study period. Among those with type 2 diabetes, the incidence increased in nonindigenous people (annual percentage change, 2.2%; 95% CI, 0.4%-4.1%) with the greatest increases in those younger than 50 and those older than 80 years. No significant change over time was observed in indigenous people, although the adjusted incident rate ratio for indigenous versus nonindigenous was 4.03 (95% CI, 3.68-4.41). LIMITATIONS: Lack of covariates such as comorbid conditions, medication use, measures of quality of care, and baseline kidney function. CONCLUSIONS: The age-standardized annual incidence of ESKD increased in Australia from 2002 to 2013 for nonindigenous people with type 2 diabetes but was stable for people with type 1 diabetes. Efforts to prevent the development of ESKD, especially among indigenous Australians and those with early-onset type 2 diabetes, are warranted.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Koye DN, Magliano DJ, Reid CM, et al. Trends in Incidence of ESKD in People With Type 1 and Type 2 Diabetes in Australia, 2002-2013. Am J Kidney Dis. 2018. PMID: 30579709. doi:10.1053/j.ajkd.2018.10.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。